HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- tetradecylhexahydro- 1H- 4,7- epoxyisoindole- 1,3(2H)- dione

has antineoplastic activity; structure in first source

Also Known As:

N-14NCTDA

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzofurans: 26
      - Cantharidin: 597
        2-tetradecylhexahydro-1H-4,7-epoxyisoindole-1,3(2H)-dione: 2

Experts

1.	Gou, Jingxin: 2 articles (10/2020 - 03/2017)
2.	He, Haibing: 2 articles (10/2020 - 03/2017)
3.	Liu, Xiaolin: 2 articles (10/2020 - 03/2017)
4.	Tang, Xing: 2 articles (10/2020 - 03/2017)
5.	Yin, Tian: 2 articles (10/2020 - 03/2017)
6.	Zhang, Yu: 2 articles (10/2020 - 03/2017)
7.	Hou, Ye: 1 article (10/2020)
8.	Jiang, Ying: 1 article (10/2020)
9.	Sun, Wanxiao: 1 article (10/2020)
10.	Tan, Xinyi: 1 article (10/2020)

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 10/08/2020 - "In Vitro and In Vivo Evaluation of SP94 Modified Liposomes Loaded with N-14NCTDA, a Norcantharimide Derivative for Hepatocellular Carcinoma-Targeting." 10/08/2020 - "The purpose of this research is to develop a liposomal drug delivery system, which can selectively target hepatocellular carcinoma (HCC) to deliver the antitumor agent N-14NCTDA, a C14 alkyl chain norcantharimide derivative of norcantharidin. "
2.	Carcinoma (Carcinomatosis) 03/30/2017 - "In conclusion, N-14NCTDA with an ideal logP is a better alternative for the treatment of primary hepatic carcinoma. "

Related Drugs and Biologics

1.	Liposomes (Liposome)
2.	Antineoplastic Agents (Antineoplastics)
3.	norcantharidin